Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA-based immunization

H L Davis1, R G Whalen

  • 1Loeb Medical Research Institute, Ottawa Civic Hospital, ON, Canada.

Molecular and Cell Biology of Human Diseases Series
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Nucleic acid immunization using plasmid DNA offers a powerful new vaccine research tool. This DNA-based immunization approach can induce broad immune responses, potentially improving public health cost-effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intramuscular and intradermal injection of DNA vaccines in mice and primates.

Methods in molecular medicine·2011
Same author

DNA-Based Immunization of Neonatal Mice.

Methods in molecular medicine·2011
Same author

Intramuscular injection of DNA vaccines in fish.

Methods in molecular medicine·2011
Same author

Immunostimulatory CpG motifs and DNA vaccines.

Methods in molecular medicine·2011
Same author

Mucosal immunization with DNA vaccines.

Methods in molecular medicine·2011
Same author

Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers.

Gene therapy·2010
Same journal

Mucopolysaccharidosis.

Molecular and cell biology of human diseases series·1995
Same journal

Degenerative and inherited neurological disorders.

Molecular and cell biology of human diseases series·1995
Same journal

Cardiovascular disease.

Molecular and cell biology of human diseases series·1995
Same journal

Duchenne muscular dystrophy.

Molecular and cell biology of human diseases series·1995
Same journal

Arthritis.

Molecular and cell biology of human diseases series·1995
Same journal

Cystic fibrosis and lung diseases.

Molecular and cell biology of human diseases series·1995
See all related articles

Area of Science:

  • Molecular immunology
  • Vaccinology
  • Gene therapy

Background:

  • Nucleic acid immunization, utilizing direct gene transfer via plasmid DNA, has emerged as a significant advancement in immunology over the past two years.
  • This method has been successfully demonstrated in various animal models, with skeletal muscle as a common target tissue for gene delivery.

Purpose of the Study:

  • To review the principles and potential of DNA-based immunization.
  • To highlight its advantages over traditional vaccination methods.
  • To discuss its implications for future vaccine development and immunotherapy.

Main Methods:

  • Direct gene transfer of plasmid DNA encoding various antigens (viral, tumor, parasitic) into animal models.
  • Assessment of induced immune responses, including antibody production and protection against challenge.

Related Experiment Videos

  • Comparison of DNA-based immunization with traditional recombinant protein vaccination.

    • Main Results:

    • DNA-based immunization successfully induces a wide spectrum of immune responses, including protective immunity against viral and parasitic infections.
    • In certain cases, such as with hepatitis B surface antigen, DNA immunization elicits superior and faster antibody responses compared to recombinant protein vaccines.
    • The rapid development and modification of DNA constructs allow for accelerated vaccine research and development.

    Conclusions:

    • DNA-based immunization represents a paradigm shift in vaccine research, offering a powerful tool for studying the immune system and developing novel vaccines and immunotherapeutics.
    • Its ability to induce robust immune responses and its cost-effectiveness hold significant promise for improving public health.
    • Further research is necessary to address safety concerns before human application, but the potential benefits are substantial.